골반장기탈출증 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 지역별 전망 및 예측(2024-2031년)
Pelvic Organ Prolapse Repair Market - Global Pelvic Organ Prolapse Repair Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 -
상품코드:1472035
리서치사:Fairfield Market Research
발행일:2024년 04월
페이지 정보:영문 202 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 골반 장기탈출증(POP) 치료 시장 규모는 2024년 4억 2,000만 달러에서 2031년 6억 달러에 달할 것으로 예측됩니다. 이 시장은 2024년부터 2031년까지 5.23%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
시장 확대는 몇 가지 매우 중요한 요인에 의해 촉진되고 있습니다. 첫째, 세계 인구의 고령화와 출산 및 호르몬 변화로 인해 골반 장기 탈출증의 유병률이 증가하고 있습니다. 인구 통계가 계속 변화함에 따라 복원 수술에 대한 수요도 급증할 것으로 예상됩니다.
둘째, 수술 기술과 의료기기의 눈부신 발전은 골반장기탈출증 치료의 상황을 완전히 바꾸어 놓았습니다. 복강경 수술과 로봇 보조 수술을 포함한 최소 침습 수술의 혁신은 기존 개복 수술에 비해 회복 시간을 단축하고 합병증 발생률을 낮추며 환자 만족도를 향상시켰습니다.
또한, 골반저 장애에 대한 인식이 높아지고 치료 옵션이 늘어나면서 골반장기탈출증에 대한 의료 지원을 받으려는 환자들의 의욕이 증가하고 있습니다. 의료 교육, 옹호 활동, 의료 서비스 접근성 향상으로 조기 진단과 치료가 더욱 촉진되어 시장 성장을 가속하고 있습니다.
이 보고서는 세계 골반장기탈출증 치료 시장에 대해 조사했으며, 시장 개요와 함께 치료별/용도별/최종사용자별/지역별 동향, 시장 진출기업의 경쟁 동향 등을 제공합니다.
목차
제1장 주요 요약
제2장 시장 개요
시장 정의와 세분화
시장 역학
밸류체인 분석
Porter의 Five Forces 분석
COVID-19의 영향 분석
우크라이나·러시아 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년
세계의 골반 장기탈출증(POP) 치료 시장 전망, 치료별, 금액(10억 달러), 2019년-2031년
세계의 골반 장기탈출증(POP) 치료 시장 전망, 용도별, 금액(10억 달러), 2019년-2031년
세계의 골반 장기탈출증(POP) 치료 시장 전망, 최종사용자별, 금액(10억 달러), 2019년-2031년
세계의 골반 장기탈출증(POP) 치료 시장 전망, 지역별, 금액(10억 달러), 2019년-2031년
제4장 북미의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년
제5장 유럽의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년
제6장 아시아태평양의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년
제7장 라틴아메리카의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년
제8장 중동 및 아프리카의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년
제9장 경쟁 구도
제조업체별과 용도별 히트맵
기업의 시장 점유율 분석, 2023년
경쟁 대시보드
기업 개요
Johnson & Johnson Services, Inc.
Coloplast A/S
Dipromed Srl
Boston Scientific Corporation
PFM medical ag
Promedon Group
Caldera Medical
Cook Medical
Medgyn Products, Inc.
Cooper Surgical, Inc.
DIMA S.L.
Digitimer Ltd.
Bray Group Ltd.
Medesign Ingenieur-Consulting GmbH
Panpac Medical Corp.
제10장 부록
LSH
영문 목차
영문목차
Global pelvic organ prolapse (POP) repair market is on track for substantial growth, with projections indicating a valuation of US$600 million by 2031, soaring from US$420 million in 2024. This impressive expansion is anticipated to occur at a compound annual growth rate (CAGR) of 5.23% during the period spanning 2024 to 2031.
Key Growth Drivers
The market's upward trajectory is fueled by several pivotal factors. Firstly, the ageing Global population, combined with occurrences such as childbirth and hormonal changes, contribute to a heightened prevalence of pelvic organ prolapse. As demographics continue to evolve, the demand for repair procedures is expected to surge accordingly.
Secondly, significant advancements in surgical techniques and medical devices have transformed the landscape of pelvic organ prolapse repair. Innovations in minimally invasive procedures, including laparoscopic and robotic-assisted surgeries, have led to reduced recovery times, lower complication rates, and enhanced patient satisfaction compared to traditional open surgeries.
Moreover, increased awareness of pelvic floor disorders and the availability of treatment options have spurred greater patient willingness to seek medical assistance for pelvic organ prolapse. Healthcare education initiatives, advocacy efforts, and improved access to healthcare services further facilitate early diagnosis and treatment, thus propelling market growth.
Major Growth Barriers
Despite the promising outlook, the market faces notable challenges. Safety concerns surrounding certain surgical techniques and devices, particularly mesh implants, have prompted heightened regulatory scrutiny and stricter approval processes. Legal challenges stemming from product liability claims also pose hurdles to market expansion, contributing to uncertainty and potentially deterring investment in research and development.
Additionally, the emergence of alternative treatment modalities, such as pelvic floor physical therapy and lifestyle modifications, presents a restraint to market growth. Some patients may prefer conservative management approaches over surgical interventions, impacting adoption rates for pelvic organ prolapse repair procedures.
Key Trends and Opportunities
Several trends and opportunities shape the future trajectory of the pelvic organ prolapse repair market. Notably, there is a significant shift towards minimally invasive procedures, driven by associated benefits such as shorter hospital stays, faster recovery times, and reduced post-operative pain.
Furthermore, there is a growing interest in biologic and tissue-engineered implants as alternatives to synthetic mesh materials. These implants offer the potential for improved integration with host tissues and reduced risk of complications, driving research and development activity in this area.
Moreover, the development of patient-specific treatment approaches presents a significant opportunity for market players to enhance treatment outcomes and gain a competitive edge. Personalized medicine approaches, tailored to individual patient characteristics, have the potential to improve clinical outcomes and patient satisfaction.
Expansion into emerging markets, particularly in regions such as Asia-Pacific, Latin America, and the Middle East, also offers significant growth potential. Rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness of pelvic floor disorders contribute to the fertile ground for market expansion in these regions.
Regional Frontrunners
Currently, North America leads the pelvic organ prolapse repair market, owing to factors such as a higher prevalence of POP, robust healthcare infrastructure, and the presence of established industry players. Europe follows closely, with a strong presence of Global industry leaders and rising awareness of pelvic floor disorders.
The Asia Pacific region is emerging as a significant player in the market, fueled by increasing awareness, a large and ageing female population, and expanding healthcare infrastructure. Medical tourism further accelerates market growth in this region.
Leaders in Global Pelvic Organ Prolapse Repair Space
Key players driving innovation and growth in the pelvic organ prolapse repair market include:
Johnson & Johnson Services, Inc.
Coloplast A/S
Dipromed Srl
Boston Scientific Corporation (American Medical Systems Inc.)
pfm medical ag
Betatech Medical
Promedon Group
Caldera Medical
Cook Medical
MEDGYN PRODUCTS, INC.
CooperSurgical, Inc.
DIMA S.L.
Digitimer Ltd
Bray Group Ltd,
medesign Ingenieur-Consulting GmbH
Panpac Medical Corp.
for.me.sa.
Bioteque America Inc.
Bliss GVS Pharma
Panpac Medical Corporation
Personal Medical Corporation
Dr. Arabin GmbH & Co.
Kangge Medical
Integra Lifesciences
Wallach Surgical Devices
Medesign
Market Segmentation
The Global Pelvic Organ Prolapse Repair Market is segmented as follows:
By Treatment:
Non-surgical:
Pessary
Pelvic Floor Muscle Therapy
Surgical:
Colpocleisis
Colporrhaphy
Sacrocolpopexy
Sacrohysteropexy
Uterosacral or Sacrospinous Ligament Fixation
By Application:
Cystocele
Urethrocele
Enterocele
Uterine Prolapse
Posterior Vaginal Wall Prolapse (dropped rectum)
By End User:
Hospitals
Specialized Clinics
Female Care Facilities
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)
Table of Contents
1. Executive Summary
1.1. Global Pelvic Organ Prolapse Repair Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031
3.1. Global Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Non-surgical
3.1.1.1.1. Pessary
3.1.1.1.2. Pelvic Floor Muscle Therapy
3.1.1.2. Surgical
3.1.1.2.1. Colpocleisis
3.1.1.2.2. Colporrhaphy
3.1.1.2.3. Sacrocolpopexy
3.1.1.2.4. Sacrohysteropexy
3.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
3.2. Global Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
